Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses

Virology Journal

Volumn 5, Issue , 2008, Pages

  Eastman, Dawnnica ^a,b   Piantadosi, Anne ^a,b   Wu, Xueling ^a,e   Forthal, Donald N ^c   Landucci, Gary ^c   Kimata, Jason T ^d   Overbaugh, Julie ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANTIBODY RESPONSE; ARTICLE; ENVELOPE GENE; EVOLUTION; GENETIC DISTANCE; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS; IC 50; LENTIVIRINAE; MACACA; MOLECULAR CLONING; NONHUMAN; PHYLOGENY; SIMIAN IMMUNODEFICIENCY VIRUS; STATISTICAL ANALYSIS; VIRUS ENTRY; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY PRODUCTION; BLOOD; CELLULAR IMMUNITY; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DISEASE TRANSMISSION; GENETIC SELECTION; GENETICS; HAPLORHINI; IMMUNOLOGY; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MONKEY DISEASE; SEQUENCE ALIGNMENT; VIROLOGY;

ANIMALIA; SIMIAN IMMUNODEFICIENCY VIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; EVOLUTION, MOLECULAR; GLYCOSYLATION; HAPLORHINI; IMMUNITY, CELLULAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; SELECTION (GENETICS); SEQUENCE ALIGNMENT; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

EID: 50049084994     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-90     Document Type: Article

References (35)

1. Selection forces and constraints on retroviral sequence variation. J Overbaugh CR Bangham, Science 2001 292 5519 1106 1109 10.1126/science.1059128 11352065
2. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. R Shankarappa JB Margolick SJ Gange AG Rodrigo D Upchurch H Farzadegan P Gupta CR Rinaldo GH Learn X He XL Huang JI Mullins, J Virol 1999 73 12 10489 10502 10559367
3. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. DP Burns RC Desrosiers, J Virol 1991 65 4 1843 1854 2002545
4. The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. PR Johnson TE Hamm S Goldstein S Kitov VM Hirsch, Virology 1991 185 1 217 228 10.1016/0042-6822(91)90769-8 1926774
5. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J Overbaugh LM Rudensey MD Papenhausen RE Benveniste WR Morton, J Virol 1991 65 12 7025 7031 1942255
6. Specific N-linked and O-linked glycosylation additions in the envelope V1 domain of SIV variants that evolve in the host alter neutralizing antibody recognition. B Chackerian L Rudensey J Overbaugh, J Virol 1997 71 10 7719 7727 9311856
7. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. LM Rudensey JT Kimata EM Long B Chackerian J Overbaugh, J Virol 1998 72 1 209 217 9420217
8. Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques. J Overbaugh LM Rudensey, J Virol 1992 66 10 5937 5948 1527847
9. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. R Wyatt J Sodroski, Science 1998 280 1884 1888 10.1126/science.280.5371.1884 9632381
10. Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques. WM Blay S Gnanakaran B Foley NA Doria-Rose BT Korber NL Haigwood, J Virol 2006 80 2 999 1014 16379001 10.1128/JVI.80.2.999-1014.2006
11. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. C Cheng-Mayer A Brown J Harouse PA Luciw AJ Mayer, J Virol 1999 73 7 5294 5300 10364275
12. Characterization of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques. SV Narayan S Mukherjee F Jia Z Li C Wang L Foresman C McCormick-Davis EB Stephens SV Joag O Narayan, Virology 1999 256 1 54 63 10.1006/viro.1999.9605 10087226
13. Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. M Sagar X Wu S Lee J Overbaugh, J Virol 2006 80 19 9586 9598 16973562 10.1128/JVI.00141-06
14. Antibody neutralization and escape by HIV-1. X Wei JM Decker S Wang H Hui JC Kappes X Wu JF Salazar-Gonzalez MG Salazar JM Kilby MS Saag NL Komarova MA Nowak BH Hahn PD Kwong GM Shaw, Nature 2003 422 6929 307 312 10.1038/nature01470 12646921
15. A lymph-node derived cytopathic simian immunodeficieny virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells. JT Kimata Mozaffarian, A., and Overbaugh, J., J Virol 1998 72 245 256 9420221
16. The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutation in Gag and Env. JT Kimata J Overbaugh, J Virol 1997 71 7629 7763 9311845
17. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. JT Kimata L Kuller DB Anderson P Dailey J Overbaugh, Nat Med 1999 5 5 535 541 10.1038/8414 10229230
18. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. DN Forthal G Landucci ES Daar, J Virol 2001 75 15 6953 6961 11435575 10.1128/JVI.75.15.6953-6961.2001
19. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. JT Herbeck DC Nickle GH Learn GS Gottlieb ME Curlin L Heath JI Mullins, J Virol 2006 80 4 1637 1644 16439520 10.1128/JVI.80.4.1637-1644.2006
20. HIV signature and sequence variation analysis. B Korber, Computational Analysis of HIV Molecular Sequences Dordrecht, Netherlands, Kluwer Academic Publishers, Rodrigo AGGHL, 2000 55 72
21. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. X Wei JM Decker H Liu Z Zhang RB Arani JM Kilby MS Saag X Wu GM Shaw JC Kappes, Antimicrob Agents Chemother 2002 46 6 1896 1905 12019106 10.1128/AAC.46.6.1896-1905.2002
22. A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses. T Kuwata R Byrum S Whitted R Goeken A Buckler-White R Plishka R Iyengar VM Hirsch, J Virol 2007 81 17 8891 8904 17596304 10.1128/JVI.00614-07
23. Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo. T Kuwata H Dehghani CR Brown R Plishka A Buckler-White T Igarashi J Mattapallil M Roederer VM Hirsch, J Virol 2006 80 3 1463 1475 16415023 10.1128/JVI.80.3.1463-1475.2006
24. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. B Li AD Gladden M Altfeld JM Kaldor DA Cooper AD Kelleher TM Allen, J Virol 2007 81 1 193 201 17065207 10.1128/JVI.01231-06
25. Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptors. S Pohlmann C Davis S Meister GJ Leslie C Otto JD Reeves BA Puffer A Papkalla M Krumbiegel A Marzi S Lorenz J Munch RW Doms F Kirchhoff, J Virol 2004 78 7 3223 3232 15016843 10.1128/JVI.78.7.3223-3232.2004
26. Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. SG Deeks B Schweighardt T Wrin J Galovich R Hoh E Sinclair P Hunt JM McCune JN Martin CJ Petropoulos FM Hecht, J Virol 2006 80 12 6155 6164 16731954 10.1128/JVI.00093-06
27. Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions. EE Verity D Zotos K Wilson C Chatfield VA Lawson DE Dwyer A Cunningham J Learmont W Dyer J Sullivan M Churchill SL Wesselingh D Gabuzda PR Gorry DA McPhee, J Virol 2007 81 17 9268 9278 17567690 10.1128/JVI.00650-07
28. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. SD Frost T Wrin DM Smith SL Kosakovsky Pond Y Liu E Paxinos C Chappey J Galovich J Beauchaine CJ Petropoulos SJ Little DD Richman, Proc Natl Acad Sci U S A 2005 102 51 18514 18519 16339909 10.1073/pnas.0504658102
29. Fc receptor but not complement binding is important in antibody protection against HIV. AJ Hessell L Hangartner M Hunter CE Havenith FJ Beurskens JM Bakker CM Lanigan G Landucci DN Forthal PW Parren PA Marx DR Burton, Nature 2007 449 7158 101 104 10.1038/nature06106 17805298
30. A real-time PCR-based method to independently sample single simian immunodeficiency virus genomes from macaques with a range of viral loads. D Williams J Overbaugh, J Med Primatol 2004 33 5-6 227 235 10.1111/j.1600-0684. 2004.00073.x 15525323
31. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. JD Thompson TJ Gibson F Plewniak F Jeanmougin DG Higgins, Nucleic Acids Res 1997 25 24 4876 4882 9396791 10.1093/nar/25.24.4876
32. Macclade 4: Analysis of Phylogeny and Character Evolution. DR Maddison WP Maddison, Sunderland, MA, Sinauer 2005
33. PAUP: phylogenetic analysis using parsimony. D Swofford, Champaign, Illinois Natural History Survey 3rd ed 1991
34. Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells. DN Forthal G Landucci KS Cole M Marthas JC Becerra K Van Rompay, J Virol 2006 80 18 9217 9225 16940533 10.1128/JVI.02746-05
35. Stata Statistical Software: Release 9. College Station, TX, StataCorp 9 2005